IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Jan
17
When discussing improvements in the available treatments for multiple myeloma, do small steps really equal progress?
In this week’s video, Dr. Brian G.M. Durie discusses whether or not small steps in the available treatments for multiple myeloma can be considered progress.
Jan
10
Best of ASH 2018 Teleconference
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma(...)
Jan
10
What is the difference between genetic testing, such as FISH testing, and DNA testing?
In this week’s video, Dr. Brian Durie identifies key takeaways for myeloma patients from the ASH 2016 abstracts.
Dec
13
Does a multiple myeloma patient whose disease has relapsed, need to undergo a second autologous stem cell transplant?
In this week’s video, Dr. Brian G.M. Durie discusses other options to consider if your doctor recommends a second autologous stem cell transplant.
Dec
05
How do multiple myeloma experts define cure?
In this week’s video, Dr. Brian G.M. Durie explains the two definitions for cure in multiple myeloma – functional cure and true cure. BOTTOM LINE: ​ We are still unable to define cure, but the good(...)
Dec
05
ASH 2018: MRD in Relapse
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about MRD in the Relapse setting with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Maria Victoria Mateos ((...)